Priya Singhal

Other Executive · BIOGEN INC.

Rank #22,042 SEC EDGAR (United States) ↗ Files from United States

Details

Officer of the companyPharmaceuticals & BiotechnologyBIIBSEC CIK 0001769608

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$1.8M
1-day change
▼ 1.64%
Positions on file
1
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$1.1M – $1.8M2026-09-04

Insider activity Apr 2, 2024 – Feb 9, 2026

Priya Singhal is recorded in filings to the U.S. SEC via EDGAR as officer of the company, and reported 25 transactions between Apr 2, 2024 and Feb 9, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
None
0 purchases on file
Open-market sales (code S)
$1.34M
7 sales on file priced rows only
All reported transactions
25
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

Priya Singhal sold 3,806 BIOGEN INC. (BIIB) shares for $480,508 on May 19, 2025

Unusual change in a direct holding

Flagged because the change that day in the shares this person holds directly was unusually large compared with their own earlier changes. The rows below are the open-market trades reported that day; under each share count is the balance the filing reports after that line.

Priya Singhal sold 3,806 BIOGEN INC. (BIIB) shares for $480,508 on May 19, 2025
Date Insider Transaction Shares Price Value Filing
May 19, 2025 Priya Singhal S Open-market sale 3,806 held after: 5,427.14 $126.25 $480,508 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 25 most recent rows are grouped into 23 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. BIOGEN INC. BIIB S Open-market sale 2,660 shares $531.5K at $199.83 SEC filing ↗
  2. BIOGEN INC. BIIB F Shares withheld for taxes × 2not a buy/sell decision 2,468 shares $496.5K
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    1,056 $201.18 $212.4K SEC filing ↗
    1,412 $201.18 $284.1K SEC filing ↗
  3. BIOGEN INC. BIIB M Option exercise or conversion × 2not a buy/sell decisionreported at zero 6,900 shares $0
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    4,683 $0.00reported at zero $0 SEC filing ↗
    2,217 $0.00reported at zero $0 SEC filing ↗
  4. BIOGEN INC. BIIB S Open-market sale 748 shares $134.1K at $179.30 SEC filing ↗
  5. BIOGEN INC. BIIB M Option exercise or conversionnot a buy/sell decisionreported at zero 1,829 shares $0 at $0.00 SEC filing ↗
  6. BIOGEN INC. BIIB F Shares withheld for taxesnot a buy/sell decision 582 shares $104.7K at $179.89 SEC filing ↗
  7. BIOGEN INC. BIIB S Open-market sale 517 shares $69.0K at $133.55 SEC filing ↗
  8. BIOGEN INC. BIIB M Option exercise or conversionnot a buy/sell decisionreported at zero 1,669 shares $0 at $0.00 SEC filing ↗
  9. BIOGEN INC. BIIB F Shares withheld for taxesnot a buy/sell decision 807 shares $106.7K at $132.22 SEC filing ↗
  10. BIOGEN INC. BIIB S Open-market sale 3,806 shares $480.5K at $126.25 SEC filing ↗
  11. BIOGEN INC. BIIB F Shares withheld for taxesnot a buy/sell decision 357 shares $50.9K at $142.54 SEC filing ↗
  12. BIOGEN INC. BIIB M Option exercise or conversionnot a buy/sell decisionreported at zero 1,212 shares $0 at $0.00 SEC filing ↗
  13. BIOGEN INC. BIIB F Shares withheld for taxesnot a buy/sell decision 681 shares $96.3K at $141.35 SEC filing ↗
  14. BIOGEN INC. BIIB M Option exercise or conversionnot a buy/sell decisionreported at zero 2,216 shares $0 at $0.00 SEC filing ↗
  15. BIOGEN INC. BIIB M Option exercise or conversionnot a buy/sell decisionreported at zero 1,828 shares $0 at $0.00 SEC filing ↗
  16. BIOGEN INC. BIIB F Shares withheld for taxesnot a buy/sell decision 578 shares $83.2K at $143.93 SEC filing ↗
  17. BIOGEN INC. BIIB S Open-market sale 110 shares $17.3K at $157.21 SEC filing ↗
  18. BIOGEN INC. BIIB M Option exercise or conversionnot a buy/sell decisionreported at zero 426 shares $0 at $0.00 SEC filing ↗
  19. BIOGEN INC. BIIB F Shares withheld for taxesnot a buy/sell decision 206 shares $32.5K at $157.78 SEC filing ↗
  20. BIOGEN INC. BIIB S Open-market sale 431 shares $88.0K at $204.22 SEC filing ↗
  21. BIOGEN INC. BIIB M Option exercise or conversionnot a buy/sell decisionreported at zero 1,668 shares $0 at $0.00 SEC filing ↗
  22. BIOGEN INC. BIIB F Shares withheld for taxesnot a buy/sell decision 807 shares $165.2K at $204.76 SEC filing ↗
  23. BIOGEN INC. BIIB S Open-market sale 93 shares $19.8K at $213.09 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
BIOGEN INC. BIIB Common Stock 8,043 $220.83 $1.8M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Priya Singhal reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.